ADD ON: Sartans to Slow Alzheimer's Disease: A Randomized, Open-Label, Head-to-Head, Proof-of-Concept Study of Angiotensin Receptor Blockers Versus ACE Inhibitors in Hypertensive Mild-Moderate AD Patients using Ventricular Enlargement as Primary Outcome
ADD ON: Sartans to Slow Alzheimer's Disease: A Randomized, Open-Label, Head-to-Head, Proof-of-Concept Study of Angiotensin Receptor Blockers Versus ACE Inhibitors in Hypertensive Mild-Moderate AD Patients using Ventricular Enlargement as Primary Outcome